B. Riley Wealth Advisors Inc. Decreases Holdings in The Clorox Company (NYSE:CLX)

B. Riley Wealth Advisors Inc. decreased its stake in The Clorox Company (NYSE:CLXFree Report) by 9.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,752 shares of the company’s stock after selling 408 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Clorox were worth $608,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Insight Folios Inc raised its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares during the period. Fiduciary Group LLC raised its stake in shares of Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after buying an additional 72 shares during the period. GHP Investment Advisors Inc. lifted its position in shares of Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after buying an additional 72 shares during the last quarter. SPC Financial Inc. increased its holdings in Clorox by 2.2% in the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after acquiring an additional 75 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV increased its holdings in Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after acquiring an additional 75 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CLX shares. Evercore ISI cut their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Barclays raised their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and boosted their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Citigroup raised their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, StockNews.com upgraded Clorox from a “hold” rating to a “buy” rating in a research note on Wednesday. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Clorox presently has a consensus rating of “Hold” and an average price target of $155.38.

View Our Latest Stock Analysis on Clorox

Clorox Trading Down 1.0 %

Shares of Clorox stock opened at $161.72 on Thursday. The company has a 50 day simple moving average of $163.96 and a two-hundred day simple moving average of $152.40. The firm has a market cap of $20.02 billion, a PE ratio of 56.35, a PEG ratio of 3.04 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business earned $0.49 earnings per share. The firm’s quarterly revenue was up 27.0% compared to the same quarter last year. Analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.02%. Clorox’s dividend payout ratio is 170.03%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.